We are live on
!
Find out more
Cabaletta Bio
CABA
CABA
108 hedge funds and large institutions have $228M invested in Cabaletta Bio in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,362% more call options, than puts
Call options by funds: $9.78M | Put options by funds: $397K
108% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 13
36% more capital invested
Capital invested by funds: $167M → $228M (+$60.6M)
19% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 27
14% more funds holding
Funds holding: 95 → 108 (+13)
3.14% less ownership
Funds ownership: 79.2% → 76.06% (-3.1%)
Holders
108
Holders Change
+13
Holders Change %
+13.68%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
32
Reduced
27
Closed
13
Calls
$9.78M
Puts
$397K
Net Calls
+$9.38M
Net Calls Change
+$4.57M
Top Buyers
Top Sellers
| 1 |
SCM
Superstring Capital Management
New York
|
-$3.3M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.27M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.81M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$1.2M |
| 5 |
Jane Street
New York
|
-$1.15M |
